e-learning
resources
ERJ
2001
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis
Ishii T., Keicho N., Teramoto S., Azuma A., Kudoh S., Fukuchi Y., Ouchi Y., Matsuse T.
Source:
Eur Respir J 2001; 18: 753-757
Journal Issue:
November
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ishii T., Keicho N., Teramoto S., Azuma A., Kudoh S., Fukuchi Y., Ouchi Y., Matsuse T.. Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis. Eur Respir J 2001; 18: 753-757
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals
Source: Eur Respir J 2011; 37: 791-799
Year: 2011
Desmosin as a marker for tissue injury in COPD
Source: Annual Congress 2007 - α
1
-Antitrypsin deficiency: molecular and clinical news
Year: 2007
Interstital lung diseases: update 2005
Source: Annual Congress 2005 - Clinical year in review
Year: 2005
Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013
Polymorphic variation in surfactant protein B is associated with COPD exacerbations
Source: Eur Respir J 2008; 32: 938-944
Year: 2008
Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients
Source: Eur Respir J 2008; 32: 372-378
Year: 2008
Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study
Source: Eur Respir J 2010; 36: 89-95
Year: 2010
Association between AGTTGFB1ESR1, and VDR gene variants with idiopathic pulmonary fibrosis (IPF) and pulmonary sarcoidosis (PS) clinical features
Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases
Year: 2017
Genetics variants in familial interstitial pneumonia and progressive fibrosing interstitial lung disease (PF-ILD)
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021
Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis
Source: Eur Respir J 2002; 19: 439-446
Year: 2002
Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin
Source: Eur Respir J 2001; 18: 17S-29S
Year: 2001
Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Periostin levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
COPACETIC, a genome-wide association study on chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010
Genetic susceptibility and pulmonary fibrosis
Source: Annual Congress 2005 - Idiopathic pulmonary fibrosis: new concepts in its pathogenesis and management
Year: 2005
Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
CTLA4 gene polymorphisms are associated with chronic bronchitis
Source: Eur Respir J 2009; 34: 598
Year: 2009
Screening for α1-Pi deficiency in patients with lung diseases
Source: Eur Respir J 2002; 20: 319-324
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept